Genesis Therapeutics Company
GEMS AI platform combines physics and deep learning to accelerate the discovery of novel small molecule drugs.
Investors
Connections from
Industry:
Early Drug Development
Headquarters:
USA
Total Funding:
$280M
Founded Date:
2019